C16ORF88 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.584200E-01
Normal-vs-Stage2
9.967600E-01
Normal-vs-Stage3
4.113000E-01
Normal-vs-Stage4
4.620000E-01
Stage1-vs-Stage2
7.464000E-01
Stage1-vs-Stage3
3.489000E-01
Stage1-vs-Stage4
3.655800E-01
Stage2-vs-Stage3
1.517040E-01
Stage2-vs-Stage4
3.903600E-01
Stage3-vs-Stage4
1.943390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.190000E-01
Normal-vs-AfricanAmerican
7.810800E-01
Normal-vs-Asian
9.111400E-01
Caucasian-vs-AfricanAmerican
7.574400E-01
Caucasian-vs-Asian
6.570800E-01
AfricanAmerican-vs-Asian
6.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.675600E-01
Normal-vs-Female
9.192200E-01
Male-vs-Female
7.826800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.987800E-01
Normal-vs-Age(41-60Yrs)
8.590800E-01
Normal-vs-Age(61-80Yrs)
8.389200E-01
Normal-vs-Age(81-100Yrs)
8.282200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.001200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.371200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.847200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.777760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.416200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.609200E-01
Normal-vs-Daily Drinker
5.496800E-01
Normal-vs-Weekly Drinker
8.562000E-01
Normal-vs-Occasional Drinker
9.286200E-01
Normal-vs-Social Drinker
7.982600E-01
Non Drinker-vs-Daily Drinker
6.449200E-01
Non Drinker-vs-Weekly Drinker
6.660400E-01
Non Drinker-vs-Occasional Drinker
3.202600E-01
Non Drinker-vs-Social Drinker
1.670590E-01
Daily Drinker-vs-Weekly Drinker
4.508600E-01
Daily Drinker-vs-Occasional Drinker
2.221400E-01
Daily Drinker-vs-Social Drinker
1.070200E-01
Weekly Drinker-vs-Occasional Drinker
6.489400E-01
Weekly Drinker-vs-Social Drinker
4.394800E-01
Occasional Drinker-vs-Social Drinker
8.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.725600E-01
Normal-vs-Grade 2
3.142000E-02
Normal-vs-Grade 3
4.209800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.438760E-03
Grade 1-vs-Grade 3
2.366600E-04
Grade 1-vs-Grade 4
2.725600E-01
Grade 2-vs-Grade 3
6.838300E-02
Grade 2-vs-Grade 4
3.142000E-02
Grade 3-vs-Grade 4
4.209800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.261200E-01
Normal-vs-NonDiabetic
9.725800E-01
Diabetic-vs-NonDiabetic
1.517760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.736400E-01
Normal-vs-NoPancreatitis
8.711000E-01
Pancreatitis-vs-NoPancreatitis
2.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.780200E-01
Normal-vs-N1
9.867800E-01
N0-vs-N1
9.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.201400E-01
Normal-vs-TP53-NonMutant
8.281000E-01
TP53-Mutant-vs-TP53-NonMutant
1.95131999999321E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
